10-70091910-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000373255.9(MACROH2A2):āc.433G>Cā(p.Gly145Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000194 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Uncertain significancein ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G145A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000373255.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MACROH2A2 | NM_018649.3 | c.433G>C | p.Gly145Arg | missense_variant | 4/9 | ENST00000373255.9 | NP_061119.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MACROH2A2 | ENST00000373255.9 | c.433G>C | p.Gly145Arg | missense_variant | 4/9 | 1 | NM_018649.3 | ENSP00000362352 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000235 AC: 59AN: 250870Hom.: 0 AF XY: 0.000258 AC XY: 35AN XY: 135670
GnomAD4 exome AF: 0.000199 AC: 291AN: 1461762Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 147AN XY: 727174
GnomAD4 genome AF: 0.000145 AC: 22AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 29, 2022 | The c.433G>C (p.G145R) alteration is located in exon 4 (coding exon 3) of the H2AFY2 gene. This alteration results from a G to C substitution at nucleotide position 433, causing the glycine (G) at amino acid position 145 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at